METOPROLOL AND MEPHENYTOIN OXIDATION POLYMORPHISMS IN FAR EASTERN ORIENTAL SUBJECTS - JAPANESE VERSUS MAINLAND CHINESE

被引:228
作者
HORAI, Y
NAKANO, M
ISHIZAKI, T
ISHIKAWA, K
ZHOU, HH
ZHOU, BJ
LIAO, CL
ZHANG, LM
机构
[1] NATL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOYAMA 1-21-2,SHINJUKU KU,TOKYO 162,JAPAN
[2] HUNAN MED COLL,NATL TRAINING CTR CLIN PHARMACOL,CHANGSHA,PEOPLES R CHINA
[3] NIHON UNIV,SCH MED,DEPT PHARMACOL,TOKYO 101,JAPAN
[4] SHIONOGI & CO LTD,SHIONOGI RES LABS,OSAKA 553,JAPAN
关键词
D O I
10.1038/clpt.1989.126
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:198 / 207
页数:10
相关论文
共 45 条
[11]  
HORAI Y, 1988, Rational Drug Therapy, V22, P1
[12]   N-ACETYLATION PHENOTYPING WITH DAPSONE IN A MAINLAND CHINESE POPULATION [J].
HORAI, Y ;
ZHOU, HH ;
ZHANG, LM ;
ISHIZAKI, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) :81-87
[13]   MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].
INABA, T ;
JURIMA, M ;
NAKANO, M ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676
[14]   DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS [J].
INABA, T ;
OTTON, SV ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) :218-223
[15]   MEPHENYTOIN HYDROXYLATION IN THE CUNA AMERINDIANS OF PANAMA [J].
INABA, T ;
JORGE, LF ;
ARIAS, TD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) :75-79
[16]  
INABA T, 1986, AM J HUM GENET, V38, P768
[17]  
INABA T, 1985, DRUG METAB DISPOS, V13, P443
[18]   EVIDENCE FOR POLYMORPHIC OXIDATION OF SPARTEINE IN JAPANESE SUBJECTS [J].
ISHIZAKI, T ;
EICHELBAUM, M ;
HORAI, Y ;
HASHIMOTO, K ;
CHIBA, K ;
DENGLER, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) :482-485
[19]   METOPROLOL AND DEBRISOQUIN METABOLISM IN NIGERIANS - LACK OF EVIDENCE FOR POLYMORPHIC OXIDATION [J].
IYUN, AO ;
LENNARD, MS ;
TUCKER, GT ;
WOODS, HF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :387-394
[20]   GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].
JACQZ, E ;
HALL, SD ;
BRANCH, RA .
HEPATOLOGY, 1986, 6 (05) :1020-1032